Clinical trial
Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed…
NCT00104793 · Japan Multinational Trial Organization, Other · Completed
Key facts
| NCT number | NCT00104793 |
|---|---|
| Title | Irinotecan and Carboplatin in Treating Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer |
| Official title | Phase II Study of Weekly Irinotecan and Carboplatin in Extensive-Stage Small-Cell Lung Cancer |
| Lead sponsor | Japan Multinational Trial Organization, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, irinotecan hydrochloride |
| Enrollment | 55 |
| Start date | Jun 1, 2003 |
| Primary completion | Feb 1, 2007 |
| Completion | Nov 1, 2008 |
| First posted | Mar 4, 2005 |
| Last update posted | May 30, 2013 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: